People
Anti-aging organization SENS Research Foundation sacked Chief Science Officer Aubrey de Grey over concerns he has attempted to influence an investigation of sexual harassment claims filed against him.
David Sabatini had initially been suspended from his position, but following the conclusion of the investigation, he was terminated over the weekend.
Woodcock faces heavy opposition from an evenly divided U.S. Senate, particularly from West Virginia Sen. Joe Manchin, who has been critical of the approval process for Biogen’s Aduhelm, formerly known as aducanumab.
The passing of the baton was announced late Thursday. Duato will take over as CEO on Jan. 3, 2022.
Cerner has appointed former Google Health boss David Feinberg as its new chief executive and president effective October 1, 2021.
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
The latest biopharma insider trading scandal stems from Pfizer’s acquisition of Medivation in 2016.
Two months after Athira placed its CEO Leen Kawas, on temporary leave, the company has appointed new execs to its team. It is also rigorously advancing its Alzheimer’s program.
Eli Lilly is undertaking a strategic transformation that will result in the formation of new business units.
While treatments exist to manage the symptoms of the disease, nothing has proven to be curative – yet. Several biopharma companies are working hard to change that.
PRESS RELEASES